Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,680 | 19 | 81.0% |
| Food and Beverage | $8,566 | 376 | 17.5% |
| Travel and Lodging | $643.93 | 5 | 1.3% |
| Gift | $68.91 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $44,536 | 192 | $0 (2024) |
| ABBVIE INC. | $764.56 | 47 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $682.92 | 26 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $385.79 | 28 | $0 (2023) |
| Ardelyx, Inc. | $343.50 | 17 | $0 (2024) |
| Allergan Inc. | $337.85 | 10 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $185.84 | 7 | $0 (2024) |
| RedHill Biopharma Inc. | $183.40 | 10 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $175.25 | 9 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $154.15 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $648.57 | 28 | Phathom Pharmaceuticals, Inc. ($185.84) |
| 2023 | $793.59 | 42 | Gilead Sciences, Inc. ($259.13) |
| 2022 | $1,032 | 50 | Gilead Sciences, Inc. ($378.44) |
| 2021 | $974.07 | 57 | Gilead Sciences, Inc. ($374.00) |
| 2020 | $2,146 | 34 | Gilead Sciences, Inc. ($1,736) |
| 2019 | $17,986 | 73 | Gilead Sciences, Inc. ($17,125) |
| 2018 | $12,950 | 66 | Gilead Sciences, Inc. ($12,496) |
| 2017 | $12,429 | 51 | Gilead Sciences Inc ($12,003) |
All Payment Transactions
401 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.59 | General |
| 11/07/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/28/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.59 | General |
| 09/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.56 | General |
| 08/26/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: GI | ||||||
| 08/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.10 | General |
| 07/15/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Rare Disease | ||||||
| 07/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.50 | General |
| 05/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.93 | General |
| 03/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 260 | 281 | $191,661 | $61,501 |
| 2022 | 7 | 359 | 367 | $286,489 | $88,767 |
| 2021 | 7 | 459 | 493 | $297,618 | $105,674 |
| 2020 | 7 | 496 | 540 | $226,296 | $75,419 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 73 | 74 | $87,013 | $26,266 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 115 | $36,143 | $12,595 | 34.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 35 | 36 | $43,714 | $11,224 | 25.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 17 | 17 | $14,528 | $7,485 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,320 | $2,154 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 23 | $3,942 | $1,778 | 45.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 102 | 102 | $133,650 | $39,733 | 29.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 49 | 49 | $65,425 | $16,054 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 120 | $42,413 | $13,522 | 31.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 23 | 23 | $21,875 | $10,651 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $19,440 | $7,331 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $2,971 | $1,392 | 46.8% |
| 83014 | Administration of drug for helicobacter pylori | Office | 2022 | 11 | 11 | $715.00 | $84.78 | 11.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 111 | 113 | $139,555 | $45,180 | 32.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 184 | $59,800 | $22,603 | 37.8% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Office | 2021 | 40 | 41 | $53,300 | $14,165 | 26.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 30 | 30 | $26,610 | $14,128 | 53.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $13,700 | $6,498 | 47.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 39 | 44 | $3,300 | $2,258 | 68.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 38 | 41 | $1,353 | $842.04 | 62.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 92 | 92 | $113,620 | $34,205 | 30.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 184 | 209 | $36,575 | $14,063 | 38.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Office | 2020 | 24 | 24 | $21,776 | $10,220 | 46.9% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Office | 2020 | 24 | 25 | $32,500 | $7,649 | 23.5% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 67 | 76 | $5,700 | $3,900 | 68.4% |
About Dr. Joon Myung, MD
Dr. Joon Myung, MD is a Gastroenterology healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265598759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joon Myung, MD has received a total of $48,959 in payments from pharmaceutical and medical device companies, with $648.57 received in 2024. These payments were reported across 401 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,680).
As a Medicare-enrolled provider, Myung has provided services to 1,574 Medicare beneficiaries, totaling 1,681 services with total Medicare billing of $331,361. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Flushing, NY
- Active Since 12/29/2006
- Last Updated 08/13/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1265598759
Products in Payments
- Vemlidy (Drug) $27,727
- ZENPEP (Drug) $1,031
- IBSRELA (Drug) $343.50
- CREON (Drug) $313.64
- XIFAXAN (Drug) $287.50
- VOQUEZNA (Drug) $185.84
- Talicia (Drug) $183.40
- MAVYRET (Drug) $162.27
- CLENPIQ (Drug) $138.78
- Mavyret (Drug) $126.14
- Vascepa (Drug) $117.76
- Amitiza (Drug) $117.30
- Prolia (Biological) $107.62
- XIFAXANIBSD (Drug) $100.90
- REMICADE (Biological) $88.94
- STEGLATRO (Drug) $81.95
- LINZESS (Drug) $77.37
- OCALIVA (Drug) $76.54
- EVIS EXERA (Device) $68.91
- MOVIPREP (Drug) $61.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Flushing
Stephen Esposito, Md, MD
Gastroenterology — Payments: $247,830
Dr. Jianlin Xie, M.d, M.D
Gastroenterology — Payments: $117,070
Chang Ho Suk, Md, MD
Gastroenterology — Payments: $74,085
Dr. Sang Kim, M.d, M.D
Gastroenterology — Payments: $39,975
Sing Chan, M.d, M.D
Gastroenterology — Payments: $24,167
Dr. Constantine Fisher, Md, MD
Gastroenterology — Payments: $15,113